Literature DB >> 8384903

Treatment of osteoporosis with vitamin D3.

M Shiraki1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384903     DOI: 10.1007/bf01621900

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  10 in total

1.  Calcitriol treatment is not effective in postmenopausal osteoporosis.

Authors:  S M Ott; C H Chesnut
Journal:  Ann Intern Med       Date:  1989-02-15       Impact factor: 25.391

2.  1,25(OH)2 vitamin D3 in osteoporosis--a pilot study.

Authors:  H G Haas; M A Dambacher; J Guncaga; T Lauffenburger; B Lämmle; J Olah
Journal:  Horm Metab Res       Date:  1979-02       Impact factor: 2.936

3.  1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis.

Authors:  J C Gallagher; C M Jerpbak; W S Jee; K A Johnson; H F DeLuca; B L Riggs
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

4.  Treatment of osteoporosis with 1-alpha-hydroxycholecalciferol and calcium.

Authors:  V Hoikka; E M Alhava; A Aro; P Karjalainen; V Rehnberg
Journal:  Acta Med Scand       Date:  1980

5.  1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover.

Authors:  A G Need; M Horowitz; J C Philcox; B E Nordin
Journal:  Miner Electrolyte Metab       Date:  1985

6.  Calcitriol in the treatment of postmenopausal osteoporosis.

Authors:  J F Aloia; A Vaswani; J K Yeh; K Ellis; S Yasumura; S H Cohn
Journal:  Am J Med       Date:  1988-03       Impact factor: 4.965

7.  Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.

Authors:  C Christiansen; M S Christensen; P Rødbro; C Hagen; I Transbøl
Journal:  Eur J Clin Invest       Date:  1981-08       Impact factor: 4.686

8.  Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3.

Authors:  H Orimo; M Shiraki; T Hayashi; T Nakamura
Journal:  Bone Miner       Date:  1987-10

9.  Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases.

Authors:  T R Dykman; K M Haralson; O S Gluck; W A Murphy; S L Teitelbaum; T J Hahn; B H Hahn
Journal:  Arthritis Rheum       Date:  1984-12

10.  Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).

Authors:  M Shiraki; H Orimo; H Ito; I Akiguchi; J Nakao; R Takahashi; S Ishizuka
Journal:  Endocrinol Jpn       Date:  1985-04
  10 in total
  1 in total

1.  Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson's disease.

Authors:  Y Sato; S Manabe; H Kuno; K Oizumi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.